HKD18.54
0.76% yesterday
Hong Kong, Apr 03, 10:08 am CET
ISIN
CNE100000FN7
Symbol
1099
Index
Sector
Industry

Sinopharm Group Stock price

HKD18.54
-1.04 5.31% 1M
-3.41 15.54% 6M
-2.76 12.96% YTD
-2.01 9.78% 1Y
+0.08 0.43% 3Y
+1.10 6.31% 5Y
-12.96 41.14% 10Y
Hong Kong, Closing price Thu, Apr 03 2025
+0.14 0.76%
ISIN
CNE100000FN7
Symbol
1099
Index
Sector
Industry

Key metrics

Market capitalization HKD57.86b
Enterprise Value HKD159.79b
P/E (TTM) P/E ratio 7.57
EV/Sales (TTM) EV/Sales 0.25
P/S ratio (TTM) P/S ratio 0.09
P/B ratio (TTM) P/B ratio 0.71
Dividend yield 3.93%
Last dividend (FY24) HKD0.73
Revenue growth (TTM) Revenue growth -3.94%
Revenue (TTM) Revenue HKD633.73b
EBIT (operating result TTM) EBIT HKD18.76b
EPS (TTM) EPS HKD2.45
P/E forward 6.98
P/S forward 0.09
EV/Sales forward 0.25
Show more

Is Sinopharm Group a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Sinopharm Group Stock Analysis

Unlock Scores for Free

Analyst Opinions

17 Analysts have issued a Sinopharm Group forecast:

12x Buy
71%
4x Hold
24%
1x Sell
6%

Analyst Opinions

17 Analysts have issued a Sinopharm Group forecast:

Buy
71%
Hold
24%
Sell
6%

Financial data from Sinopharm Group

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
633,731 633,731
4% 4%
100%
- Direct Costs 586,228 586,228
3% 3%
93%
47,504 47,504
11% 11%
7%
- Selling and Administrative Expenses 23,614 23,614
3% 3%
4%
- Research and Development Expense - -
-
-
23,890 23,890
17% 17%
4%
- Depreciation and Amortization 5,132 5,132
5% 5%
1%
EBIT (Operating Income) EBIT 18,757 18,757
22% 22%
3%
Net Profit 7,643 7,643
23% 23%
1%

In millions HKD.

Don't miss a Thing! We will send you all news about Sinopharm Group directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sinopharm Group Co., Ltd. is a distributor of pharmaceutical and healthcare products and a value added supply chain service provider in the People's Republic of China. It operates through the following business segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment provides distribution, logistics and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers and other suppliers. The Medical Devices segment consists of the distribution of medical devices in China. The Retail Pharmacy segment refers to the network of retail drug stores in major cities of China via direct operations and franchises. The Other Business segment comprises of the production and sale of pharmaceutical products, chemical reagents and laboratory supplies. The company was founded on January 8, 2003 and is headquartered in Shanghai, China.

Head office China
Employees 108,217
Founded 2003
Website ir.sinopharmgroup.com.cn

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today